ARTICLE | Company News
TransPharma, Eli Lilly deal
June 16, 2008 7:00 AM UTC
TransPharma granted Lilly an exclusive, worldwide development and commercialization license to ViaDerm-hPTH (1-34), a transdermal patch to treat osteoporosis. Lilly also received a non-exclusive lice...